ReviewDiagnostics (Basel, Switzerland)2022

A Systematic Review of Companion Diagnostic Tests by Immunohistochemistry for the Screening of Alectinib-Treated Patients in ALK-Positive Non-Small Cell Lung Cancer.

Sulim Kang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.